Assessing External Validity Over Worst-case Subpopulations
  Study populations are typically sampled from limited points in space and
time, and marginalized groups are underrepresented. To assess the external
validity of randomized and observational studies, we propose and evaluate the
worst-case treatment effect (WTE) across all subpopulations of a given size,
which guarantees positive findings remain valid over subpopulations. We develop
a semiparametrically efficient estimator for the WTE that analyzes the external
validity of the augmented inverse propensity weighted estimator for the average
treatment effect. Our cross-fitting procedure leverages flexible nonparametric
and machine learning-based estimates of nuisance parameters and is a regular
root-$n$ estimator even when nuisance estimates converge more slowly. On real
examples where external validity is of core concern, our proposed framework
guards against brittle findings that are invalidated by unanticipated
population shifts.
